Strattera capsules of5mg, 10mg, 18mg, 25mg, 40mg, 60mg, 80 mg and mg can be usedIn the judgement of ADHD. This drug does not refer to psychostimulants or to food derivatives, so it makes not cause ...

Strattera is made and marketed by Eli Lilly. Annual sales of branded and generic atomoxetine hydrochloride capsules are estimated to be more than $530 million. FDA approves Sun's generic Strattera ...

Strattera is currently available as 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg strength capsules in 30-count bottles. For more information visit FDA.gov.

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ...

MasterPharm, LLC. is voluntarily recalling 1 lot of Finasteride Plus 1.25mg, capsules to the consumer level. The Finasteride Plus capsules have been found to contain undeclared minoxidil, an ...

The recalled lot of Finasteride Plus 1.25mg is marked with 02-27-2020:04@11 and a Beyond Use Date of August 25, 2020, and was distributed nationwide on a patient-specific prescription basis only.

The FDA has approved revisions to the safety labeling for atomoxetine HCl (Strattera) and for a class of drugs approved to treat major depressive disorder. News & Perspective Drugs & Diseases ...

MORRISTOWN, N.J., Sept. 1 /PRNewswire/ -- Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention ...

Travel By India.com; Screenbox; The Health Site; Bollywood Life; Cricket Country ...

Sales of Triamterene Hydrochlorothiazide 37.5/25mg Capsules, at Average Wholesale Price (AWP) were approximately $111 million for the 12 months ending October 2011, according to Wolters Kluwer.

Sun Pharma announced that the USFDA has granted a tentative approval for an Abbreviated New Drug Application (ANDA) for generic Strattera?, atomoxetine hydrochloride capsules.

Actavis Receives FDA Approval of Atomoxetine HCl Capsules MORRISTOWN, N.J., Sept 01, 2010 /PRNewswire via COMTEX/ -- Actavis has received approval from the U.S. Food & Drug Administration to ...